Senators press pharmaceutical CEO on why weight loss drugs like Ozempic cost less abroad
The CEO of Novo Nordisk testified Tuesday that the pharmaceutical company has little control over what patients pay for its blockbuster diabetes and weight loss drugs, even as skeptical senators criticized the Danish company for charging Americans …